Alix Ashare

2.5k total citations
46 papers, 1.5k citations indexed

About

Alix Ashare is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Alix Ashare has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 14 papers in Epidemiology. Recurrent topics in Alix Ashare's work include Cystic Fibrosis Research Advances (17 papers), Neonatal Respiratory Health Research (13 papers) and Vibrio bacteria research studies (5 papers). Alix Ashare is often cited by papers focused on Cystic Fibrosis Research Advances (17 papers), Neonatal Respiratory Health Research (13 papers) and Vibrio bacteria research studies (5 papers). Alix Ashare collaborates with scholars based in United States, United Kingdom and Egypt. Alix Ashare's co-authors include Gary W. Hunninghake, Amanda Nymon, Thomas H. Hampton, Kevin C. Doerschug, Deborah A. Hogan, Martha M. Monick, Bruce A. Stanton, Gregory A. Schmidt, Linda S. Powers and David A. Armstrong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Alix Ashare

45 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alix Ashare United States 25 581 548 353 272 223 46 1.5k
Lili Tao China 21 186 0.3× 608 1.1× 327 0.9× 297 1.1× 200 0.9× 80 1.8k
Cynthia L. Leaphart United States 17 500 0.9× 322 0.6× 196 0.6× 252 0.9× 131 0.6× 25 1.6k
Gernot Fritsche Austria 20 212 0.4× 245 0.4× 146 0.4× 168 0.6× 270 1.2× 30 1.5k
Benjamin T. Kopp United States 24 889 1.5× 517 0.9× 418 1.2× 189 0.7× 88 0.4× 105 1.9k
Andrea Schroll Austria 26 154 0.3× 428 0.8× 258 0.7× 324 1.2× 198 0.9× 49 2.6k
Janette Bester South Africa 21 488 0.8× 515 0.9× 249 0.7× 172 0.6× 246 1.1× 49 1.8k
J M Danforth United States 19 266 0.5× 358 0.7× 427 1.2× 1.0k 3.8× 139 0.6× 21 1.9k
R. Chiron France 26 1.5k 2.6× 365 0.7× 347 1.0× 108 0.4× 163 0.7× 93 2.1k
Steven C. Gribar United States 13 506 0.9× 314 0.6× 200 0.6× 446 1.6× 170 0.8× 20 1.6k
Ward M. Richardson United States 14 584 1.0× 224 0.4× 177 0.5× 267 1.0× 140 0.6× 25 1.4k

Countries citing papers authored by Alix Ashare

Since Specialization
Citations

This map shows the geographic impact of Alix Ashare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alix Ashare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alix Ashare more than expected).

Fields of papers citing papers by Alix Ashare

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alix Ashare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alix Ashare. The network helps show where Alix Ashare may publish in the future.

Co-authorship network of co-authors of Alix Ashare

This figure shows the co-authorship network connecting the top 25 collaborators of Alix Ashare. A scholar is included among the top collaborators of Alix Ashare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alix Ashare. Alix Ashare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vlasac, Irma, Diane Mellinger, Thomas H. Hampton, et al.. (2025). Lung-kidney axis in cystic fibrosis: Early urinary markers of kidney injury correlate with neutrophil activation and worse lung function. Journal of Cystic Fibrosis. 24(3). 613–620. 1 indexed citations
3.
Li, Zhongyou, Roxanna Barnaby, Amanda Nymon, et al.. (2024). P. aeruginosa tRNA-fMet halves secreted in outer membrane vesicles suppress lung inflammation in cystic fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(5). L574–L588. 4 indexed citations
4.
Demers, Elora G., et al.. (2023). Mrs4 loss of function in fungi during adaptation to the cystic fibrosis lung. mBio. 14(4). e0117123–e0117123. 7 indexed citations
5.
Demers, Elora G., Jason Stajich, Alix Ashare, Patricia Occhipinti, & Deborah A. Hogan. (2021). Balancing Positive and Negative Selection: In Vivo Evolution of Candida lusitaniae MRR1. mBio. 12(2). 11 indexed citations
6.
Lofgren, Lotus, et al.. (2021). Aspergillus fumigatus In-Host HOG Pathway Mutation for Cystic Fibrosis Lung Microenvironment Persistence. mBio. 12(4). e0215321–e0215321. 17 indexed citations
7.
Carroll, James L., et al.. (2021). Safety of research bronchoscopy with BAL in stable adult patients with cystic fibrosis. PLoS ONE. 16(1). e0245696–e0245696. 3 indexed citations
8.
9.
Armstrong, David A., Haley F. Hazlett, Diane Mellinger, et al.. (2020). Extracellular Vesicles from Pseudomonas aeruginosa Suppress MHC-Related Molecules in Human Lung Macrophages. ImmunoHorizons. 4(8). 508–519. 26 indexed citations
10.
Stanton, Bruce A., Thomas H. Hampton, & Alix Ashare. (2020). SARS-CoV-2 (COVID-19) and cystic fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 319(3). L408–L415. 33 indexed citations
11.
Hazlett, Haley F., Thomas H. Hampton, David A. Armstrong, et al.. (2020). Altered iron metabolism in cystic fibrosis macrophages: the impact of CFTR modulators and implications for Pseudomonas aeruginosa survival. Scientific Reports. 10(1). 10935–10935. 26 indexed citations
12.
Armstrong, David A., Youdinghuan Chen, Jacqueline Y. Channon, et al.. (2019). DNA Methylation Changes in Regional Lung Macrophages Are Associated with Metabolic Differences. ImmunoHorizons. 3(7). 274–281. 14 indexed citations
13.
Mellinger, Diane, David A. Armstrong, Haley F. Hazlett, et al.. (2019). Functional and metabolic impairment in cigarette smoke-exposed macrophages is tied to oxidative stress. Scientific Reports. 9(1). 9624–9624. 40 indexed citations
14.
Armstrong, David A., Amanda Nymon, Carol S. Ringelberg, et al.. (2017). Pulmonary microRNA profiling: implications in upper lobe predominant lung disease. Clinical Epigenetics. 9(1). 56–56. 35 indexed citations
15.
Hogan, Deborah A., Sven D. Willger, Emily L. Dolben, et al.. (2016). Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease. PLoS ONE. 11(3). e0149998–e0149998. 90 indexed citations
16.
Skopelja‐Gardner, Sladjana, B. JoNell Hamilton, Jonathan D. G. Jones, et al.. (2016). The role for neutrophil extracellular traps in cystic fibrosis autoimmunity. JCI Insight. 1(17). e88912–e88912. 55 indexed citations
17.
Hunninghake, Gary W., Kevin C. Doerschug, Amanda Nymon, et al.. (2010). Insulin-like Growth Factor–1 Levels Contribute to the Development of Bacterial Translocation in Sepsis. American Journal of Respiratory and Critical Care Medicine. 182(4). 517–525. 49 indexed citations
18.
Durairaj, Lakshmi, Zeinab Mohamad, Janice L. Launspach, et al.. (2009). Patterns and density of early tracheal colonization in intensive care unit patients. Journal of Critical Care. 24(1). 114–121. 33 indexed citations
19.
Ashare, Alix, Amanda Nymon, Kevin C. Doerschug, et al.. (2008). Insulin-like Growth Factor-1 Improves Survival in Sepsis via Enhanced Hepatic Bacterial Clearance. American Journal of Respiratory and Critical Care Medicine. 178(2). 149–157. 36 indexed citations
20.
Ashare, Alix, Timur O. Yarovinsky, Martha M. Monick, & Gary W. Hunninghake. (2005). SEVERE SEPSIS IS ASSOCIATED WITH AN APOPTOSIS-MEDIATED DECREASE IN HEPATIC BACTERIAL CLEARANCE. CHEST Journal. 128(4). 379S–379S. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lili Tao Breakdown of academic impact, for papers by Cynthia L. Leaphart Breakdown of academic impact, for papers by Gernot Fritsche Breakdown of academic impact, for papers by Benjamin T. Kopp Breakdown of academic impact, for papers by Andrea Schroll Breakdown of academic impact, for papers by Janette Bester Breakdown of academic impact, for papers by J M Danforth Breakdown of academic impact, for papers by R. Chiron Breakdown of academic impact, for papers by Steven C. Gribar Breakdown of academic impact, for papers by Ward M. Richardson
Rankless by CCL
2026